Drug History: NAROPIN

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	NAROPIN
FDA Application No:	(NDA) 020533
Active Ingredient(s):	ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
Company:	ABRAXIS BIOSCIENCE

Label History

View the label approved on August 9, 2006 for NAROPIN, (NDA) 020533

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
8/8/2006	014	Labeling Revision	Letter Label
8/11/2004	012	Labeling Revision	Letter Label
7/17/2002	008	Control Supplement
11/14/2000	007	Manufacturing Change or Addition
2/9/2000	006	Control Supplement
6/22/2000	005	Labeling Revision
11/2/2000	002	New Dosage Regimen	Review
5/1/1998	001	Package Change
9/24/1996	000	Approval

There are no Therapeutic Equivalents